Walleye Trading
CEROW

Walleye Trading’s CERo Therapeutics Warrants CEROW Stock Holding History

Walleye Trading’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,333
Closed -$193 – 4805
2025
Q1 		$193 Sell
13,333
-57,020
-81% -$804 ﹤0.01% 3971
2024
Q4 		$584 Sell
70,353
-17,721
-20% -$193 ﹤0.01% 4171
2024
Q3 		$449 Hold
88,074
– – ﹤0.01% 4021
2024
Q2 		$1.77K Buy
88,074
+74,592
+553% +$4.37K ﹤0.01% 4080
2024
Q1 		$919 Hold
13,482
– – ﹤0.01% 4607
2023
Q4 		$317 Hold
13,482
– – ﹤0.01% 4986
2023
Q3 		$965 Hold
13,482
– – ﹤0.01% 4867
2023
Q2 		$824 Hold
13,482
– – ﹤0.01% 4591
2023
Q1 		$541 Hold
13,482
– – ﹤0.01% 4748
2022
Q4 		$581 Buy
+13,482
New +$709 ﹤0.01% 4848

Other funds holding CEROW

CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Walleye Trading's CEROW Position: Q2 2025 in Review

Walleye Trading sold out of CERo Therapeutics Warrants (CEROW) in Q2 2025, closing a stake of 13,333 shares — an estimated $193 sold.

Walleye Trading first reported a position in CEROW in Q4 2022 and held it in 10 quarters. The position peaked at $1.77K in Q2 2024. 23 funds tracked by Wall St. Rank hold CEROW as of Q2 2025.

  • Walleye Trading reported no remaining CERo Therapeutics Warrants position as of Q2 2025 after selling out during the quarter.
  • Walleye Trading sold 13,333 CERo Therapeutics Warrants shares in Q2 2025, an estimated $193.
  • Walleye Trading first reported a position in CERo Therapeutics Warrants in Q4 2022 and held it in 10 quarters.
  • Walleye Trading's CERo Therapeutics Warrants position peaked at $1.77K in Q2 2024.
  • 23 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q2 2025.

Based on Walleye Trading's 13F filing for Q2 2025, filed 13 Aug 2025.